When was Amyris founded?

Amyris was founded in 2003 and raised its 1st funding round 2 years after it was founded.

Where is Amyris located?

Amyris is headquartered in Emeryville, United States. It is registered at Emeryville, California.

How many employees does Amyris have?

As of Sep 30, 2026, the latest employee count at Amyris is 996.

Is Amyris a funded company?

Amyris is a funded company, having raised a total of $487M across 61 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on 2005.

When was the latest funding round of Amyris?

Amyris' latest funding was a $***** Post IPO round on Dec 29, 2022, with participation from 1 investor.

Where does Amyris rank among its competitors?

Amyris ranks 19th amongst 322 active competitors, of which 130 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Antheia, which secured $24M in Jan, 2026.

Who are the top competitors of Amyris?

Amyris' top competitors include Ginkgo Bioworks, Syngenta and Spark Therapeutics. Among them, Antheia secured the most recent funding round in January, 2026.

Amyris - 2026 Company Profile, Team, Funding, Competitors & Financials

Amyris is a public company based in Emeryville (United States), founded in 2003. It operates as a Developer of renewable products for industrial solutions. Amyris has raised $487M in funding from investors like Temasek, DAG Ventures and TPG. The company has 322 active competitors, including 130 funded and 76 that have exited. Its top competitors include companies like Ginkgo Bioworks, Syngenta and Spark Therapeutics.

Company Details

Developer of renewable products for industrial solutions. The company's products include consumer materials, polymers, biofuels, and lubricants. It is also developing semi-synthetic artemisinin for malaria treatment.

Website: amyris.com
Social
Registered Address: Emeryville, California

Key Metrics

Founded Year

2003

Location

Emeryville, United States

Stage

Public

Total Funding

$487M in 61 rounds

Latest Funding Round

Post IPO, Dec 29, 2022, $*****

Investors

Temasek & 25 more

Ranked

19^th among 322 active competitors

Employee Count

996 as on Sep 30, 2026

Investment & Acquisitions

EcoFabulous & 5 more

Similar Companies

Ginkgo Bioworks & 166 more

Exit Details

Public

View Amyris' full profile

Amyris is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Amyris, Inc. CIN: 550856151 , United States, Active	Dec 26, 999	-	247 (As on Dec 31, 2024)	-

Amyris got listed on Sep 28, 2010.

Click here to take a look at Amyris's IPO in detail

Amyris has raised a total funding of $487M over 61 rounds. Its first funding round was on 2005. Its latest funding round was a Post IPO round on Dec 29, 2022 for $*****. 1 investor participated in its latest round. Amyris has 25 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Amyris:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 29, 2022	4755129	Post IPO	5061422	2595783	8417565	9406633
Dec 21, 2020	5329937	Post IPO	3420279	8553951	4299346	DSM
Jun 04, 2020	2016313	Post IPO	6763187	7410624	8973807	3427927

Access funding benchmarks and valuations. Sign up today!

View details of Amyris's funding rounds and investors

Amyris' employee count trend

Amyris has 996 employees as of Sep 26. Here is Amyris's employee count trend over the years:

Uncover Amyris' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Amyris include Ginkgo Bioworks, Syngenta and Spark Therapeutics. Here is the list of Top 10 competitors of Amyris, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ginkgo Bioworks 2008, Boston (United States), Public	Autonomous labs for biotechnology, empowering scientists to design the living world	$796M	Viking Global Investors, T. Rowe Price & 53 others	81/100
2nd	Syngenta 2000, Basel (Switzerland), Acquired	Developer of technologies and sustainable farming practices for farmers	-	Analah Ventures, Europa	75/100
3rd	Spark Therapeutics 2013, Philadelphia (United States), Acquired	Developer of gene therapy for rare diseases	$82.8M	Sofinnova Investments, T. Rowe Price & 6 others	73/100
4th	Twist Bioscience 2013, San Francisco (United States), Public	Developer of a semiconductor-based DNA synthesis platform	$321M	Foresite Capital, Fidelity Investments & 39 others	72/100
5th	Beam Therapeutics 2017, Cambridge (United States), Public	Developer of gene therapy using CRISPR base editing to treat diseases	$222M	Redmile Group, Cormorant-asset & 16 others	70/100
6th	Passage Bio 2017, Philadelphia (United States), Public	Developer of gene therapies for CNS rare diseases	$226M	Access Biotechnology, Orbimed & 10 others	69/100
7th	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	Vivo Capital, Malaysian Life Sciences Capital Fund ... & 12 others	68/100
8th	AskBio 2001, Durham (United States), Acquired	Developer of AAV technologies for treating genetic and complex disorders	$235M	Vida Ventures, TPG & 4 others	68/100
9th	CureVac 2000, Tubingen (Germany), Acquired	Developer of mRNA-based therapeutics against cancer and infectious diseases	$975M	Dievini, Gates & 16 others	67/100
10th	Antheia 2013, Palo Alto (United States), Series C	Genetically engineered yeast cells to produce medicinal products	$176M	Viking Global Investors, ATHOS KG & 15 others	67/100
19th	Amyris 2003, Emeryville (United States), Public	Developer of renewable products for industrial solutions	$487M	B. Riley Financial, TriplePoint Capital & 24 others	65/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Amyris's competitors? Click here to see the top ones

Amyris has not made any investments yet. Amyris has made 6 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Feb 09, 2022	Acquisition	EcoFabulous	2006	Emeryville (United States)
Aug 24, 2021	Acquisition	MG Empower	2017	London (United Kingdom)
Jun 15, 2021	Acquisition	OLIKA	2015	New York City (United States)